4/A//SEC Filing
FREYMAN THOMAS C 4/A
Accession 0001179110-20-006518
CIK 0001551152other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:47 PM ET
Size
9.4 KB
Accession
0001179110-20-006518
Insider Transaction Report
Form 4/AAmended
AbbVie Inc.ABBV
FREYMAN THOMAS C
Director
Transactions
- Award
Common Stock, $0.01 par value
2020-05-08+2,583→ 117,342 total - Award
Common Stock, $0.01 par value
2020-05-08+2,333→ 119,675 total
Holdings
- 1,941(indirect: By Trust)
Common Stock, $0.01 par value
- 4,000(indirect: By Trust)
Common Stock, $0.01 par value
- 1,941(indirect: By Trust)
Common Stock, $0.01 par value
Footnotes (4)
- [F1]Received in exchange for 2,983 shares of Allergan plc common stock in connection with its acquisition by AbbVie Inc. Allergan shareholders received 0.8660 AbbVie shares for each Allergan share (based on the closing price of AbbVie's common stock of $84.22 on May 7, 2020).
- [F2]These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
- [F3]The reporting person's spouse is the trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
- [F4]Shares are held in an irrevocable trust for the benefit of the reporting person's son. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities.
Documents
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeother
Related Parties
1- filerCIK 0001239126
Filing Metadata
- Form type
- 4/A
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 5:47 PM ET
- Size
- 9.4 KB